Related Experiment Videos
Tissue factor pathway inhibitor and the current concept of blood coagulation
1Division of Hematology/Oncology, Jewish Hospital, Washington University Medical Center, St Louis, MO 63110, USA.
Abstract:
Tissue factor pathway inhibitor (TFPI) is a multivalent, Kunitz-type plasma proteinase inhibitor that regulates tissue factor-induced coagulation. TFPI directly inhibits activated factor X and, in a factor Xa-dependent manner, produces feedback inhibition of the factor VIIa/tissue factor catalytic complex. The properties of this inhibitor help explain the clinical need for 'extrinsic' and 'intrinsic' coagulation pathways and have led to a reformulation of the coagulation cascade. In the revised hypothesis, factor VIIa/tissue factor is responsible for the initiation of coagulation but, owing to TFPI-mediated feedback inhibition, amplification of the procoagulant response though the actions of factor VIII, IX and XI is required for sustained haemostasis.
Insights
Tissue factor pathway inhibitor (TFPI) regulates blood clotting by inhibiting key enzymes. Its feedback inhibition mechanism explains the necessity of intrinsic coagulation pathways for sustained hemostasis.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Tissue factor pathway inhibitor (TFPI) is a critical regulator of the extrinsic coagulation pathway.
- TFPI is a Kunitz-type serine protease inhibitor found in plasma.
- It directly inhibits activated Factor X (FXa) and indirectly inhibits the TF/FVIIa complex.
Purpose of the Study:
- To elucidate the regulatory role of TFPI in the coagulation cascade.
- To explain the clinical relevance of distinct extrinsic and intrinsic coagulation pathways.
- To propose a reformulated model of hemostasis incorporating TFPI's feedback inhibition.
Main Methods:
- Literature review and synthesis of existing data on TFPI function.
- Analysis of TFPI's inhibitory mechanisms on coagulation factors.
- Re-evaluation of the classical coagulation cascade model.
Main Results:
- TFPI directly inhibits FXa, a key enzyme in the common pathway.
- TFPI mediates feedback inhibition of the TF/FVIIa complex, limiting initial clot formation.
- This feedback inhibition necessitates the activation of the intrinsic pathway for robust hemostasis.
Conclusions:
- TFPI plays a crucial role in controlling the initiation of coagulation.
- The properties of TFPI necessitate the amplification provided by the intrinsic pathway for effective hemostasis.
- A revised model of coagulation highlights the interplay between extrinsic initiation and intrinsic amplification, regulated by TFPI.